Merck Serono targets convenient, affordable medicines for patients at risk

被引：0
|
作者：
不详
机构：
来源：
CARDIOVASCULAR JOURNAL OF AFRICA | 2009年 / 20卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：77 / 77
页数：1
相关论文
共 50 条
  • [41] A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients
    Tomlin, Andrew M.
    Reith, David M.
    Woods, David J.
    Lloyd, Hywel S.
    Smith, Alesha
    Fountain, John S.
    Tilyard, Murray W.
    DRUG SAFETY, 2017, 40 (12) : 1259 - 1277
  • [42] Incidence and risk of adverse perioperative events among surgical patients taking traditional Chinese herbal medicines
    Lee, Anna
    Chui, Po Tong
    Aun, Cindy S. T.
    Lau, Angel S. C.
    Gin, Tony
    ANESTHESIOLOGY, 2006, 105 (03) : 454 - 461
  • [43] A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients
    Andrew M. Tomlin
    David M. Reith
    David J. Woods
    Hywel S. Lloyd
    Alesha Smith
    John S. Fountain
    Murray W. Tilyard
    Drug Safety, 2017, 40 : 1259 - 1277
  • [44] Does the perceived risk of breast cancer recurrence and death affect the use of complementary medicines by cancer patients?
    Verma, S
    Rakovitch, E
    George, D
    Giotis, A
    Charbonneau, F
    Petrella, T
    Pignol, JP
    Trudeau, M
    Clemons, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 766S - 766S
  • [45] Effect of Chinese Herbal Medicines on Hearing Loss Risk in Rheumatoid Arthritis Patients: Retrospective Claims Analysis
    Li, Hsin-Hua
    Livneh, Hanoch
    Chen, Wei-Jen
    Fan, Wen-Lin
    Lu, Ming-Chi
    Guo, How-Ran
    Tsai, Tzung-Yi
    FRONTIERS IN MEDICINE, 2021, 8
  • [46] Patient Global Impression of Benefit–Risk (PGI-BR): Incorporating Patients’ Views of Clinical Benefit–Risk into Assessment of New Medicines
    Daniel Eek
    Katarina Halling
    Emuella Flood
    Matthew Blowfield
    Oren Meyers
    Meredith Venerus
    Jean Paty
    Richard Hermann
    Drug Safety, 2021, 44 : 1059 - 1072
  • [47] Guideline recommended treatment to targets of cardiovascular risk is inadequate in patients with inflammatory joint diseases
    Ikdahl, Eirik
    Wibetoe, Grunde
    Rollefstad, Silvia
    Salberg, Anne
    Bergsmark, Kjetil
    Kvien, Tore K.
    Olsen, Inge C.
    Soldal, Dag Magnar
    Bakland, Gunnstein
    Lexberg, Ase
    Fevang, Bjorg Tilde Svanes
    Gulseth, Hans Christian
    Haugeberg, Glenn
    Semb, Anne Grete
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 274 : 311 - 318
  • [48] Cardiovascular risk in patients achieving low-density lipoprotein cholesterol and particle targets
    Toth, Peter P.
    Grabner, Michael
    Punekar, Rajeshwari S.
    Quimbo, Ralph A.
    Cziraky, Mark J.
    Jacobson, Terry A.
    ATHEROSCLEROSIS, 2014, 235 (02) : 585 - 591
  • [49] A NOVEL INSULIN REGIMEN THAT TARGETS PATIENTS WITH RISK FACTORS OF HYPERKALEMIA DURING LIVER TRANSPLANTATION
    Xia, Victor W.
    Obaidi, Rafee
    Park, Chul Soo
    Hu, Ke-Qin
    Steadman, Randolph H.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S73 - S73
  • [50] Antiseptic effect of a novel alcohol-free mouthwash: A convenient prophylactic alternative for high-risk patients
    Bahna, Paul
    Hanna, Hend A.
    Dvorak, Tanya
    Vaporciyan, Ara
    Chambers, Mark
    Raad, Issam
    ORAL ONCOLOGY, 2007, 43 (02) : 159 - 164
12345